Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy CounterPath Corporation (CPAH) stocks in Canada

Learn how to easily invest in CounterPath Corporation stocks.

CounterPath Corporation is a software-application business based in the US. CounterPath Corporation stocks (CPAH.US) are listed on the NASDAQ and all prices are listed in US Dollars. CounterPath Corporation employs 72 staff and has a trailing 12-month revenue of around $13.9 million.

How to buy shares in CounterPath Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – CPAH – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Is it a good time to buy CounterPath Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

CounterPath Corporation stock price (NASDAQ:CPAH)

Use our graph to track the performance of CPAH stocks over time.

CounterPath Corporation shares at a glance

Information last updated 2021-04-11.
52-week range$3.38 - $3.57
50-day moving average $3.44
200-day moving average $3.26
Wall St. target price$3.38
PE ratio 32.6168
Dividend yield N/A (0%)
Earnings per share (TTM) $0.11

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is CounterPath Corporation under- or over-valued?

Valuing CounterPath Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of CounterPath Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

CounterPath Corporation's P/E ratio

CounterPath Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, CounterPath Corporation shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

CounterPath Corporation's EBITDA

CounterPath Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.1 million.

The EBITDA is a measure of a CounterPath Corporation's overall financial performance and is widely used to measure a its profitability.

CounterPath Corporation financials

Revenue TTM $13.9 million
Operating margin TTM 7.39%
Gross profit TTM $10 million
Return on assets TTM 4.95%
Return on equity TTM 24.72%
Profit margin 5.3%
Book value $0.63
Market capitalisation $22.5 million

TTM: trailing 12 months

CounterPath Corporation share dividends

We're not expecting CounterPath Corporation to pay a dividend over the next 12 months.

Have CounterPath Corporation's shares ever split?

CounterPath Corporation's shares were split on a 1:10 basis on 1 November 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your CounterPath Corporation shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for CounterPath Corporation shares which in turn could have impacted CounterPath Corporation's share price.

CounterPath Corporation share price volatility

Over the last 12 months, CounterPath Corporation's shares have ranged in value from as little as $3.38 up to $3.5663. A popular way to gauge a stock's volatility is its "beta".

CPAH.US volatility(beta: 1.65)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while CounterPath Corporation's is 1.6497. This would suggest that CounterPath Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

CounterPath Corporation overview

CounterPath Corporation designs, develops, and sells software and services that enable enterprises and telecommunication service providers to deliver unified communications services over Internet protocol based networks in North America and internationally. Its products include Bria softphone suite that enables consumers and business users to make VoIP audio and video calls, send instant messages, manage their presence, share their screen, and collaborate with other users using desktop computers and laptops, smartphones, and tablets; and Bria Solo, which offers individual users to deploy their own softphones for use against SIP-based call sever. The company also offers software development kits that deliver voice, video, and messaging capabilities for desktop computers and mobile devices; Stretto Platform, a carrier-grade software platform for enterprises and service providers; Bria Teams, which delivers centralized provisioning, messaging, presence, screen sharing, video conferencing, and collaboration; and Bria Enterprise, an application for enterprises, service providers, and telecommunication channel partners to leverage the Stretto Platform to procure, distribute, provide, and manage Bria Enterprise clients from the cloud; and hosted messaging and collaboration solutions. In addition, it provides subscription, support, and maintenance services; and professional and other services, such as product configuration and customization, implementation, engineering, and training. The company sells its products and services through its own and third-party online stores; directly using its in-house sales team; and its channel partners. It serves small, medium, and large enterprises; telecommunications service providers and Internet telephony service providers; original equipment manufacturers, value added distributors, and value added resellers serving the telecommunication market; and end users. The company was founded in 2002 and is headquartered in Vancouver, Canada.

Stocks similar to CounterPath Corporation

Frequently asked questions

CounterPath Corporation in the news

There are no recent company news
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site